Have you heard of the VALID Act and understand how it would drastically improve the quality of care provided to patients? Laboratory Developed Tests have never been regulated by the FDA. That’s why our nonprofit has to help payers sort through which genetic/genomic tests have clinical value and provide accurate results, and which do not. Insufficient regulation has provided the perfect environment for fraud, waste and abuse. If the VALID Act passes, the FDA would finally have authority to regulate these wild-west clinical tests. Please study the issue, and if your organization supports FDA oversight of clinical diagnostics, like our nonprofit organization does, please let congress know. Here is a copy of the VALID Act: https://www.congress.gov/bill/117th-congress/senate-bill/2209/text
Problem: Inaccuracies in Laboratory Developed Tests (LDTs) continue to impact patient care, which has also led to recent class action lawsuits. CLIA and CAP approvals are NOT enough, as accuracy is NOT sufficiently evaluated!
Please email us if you would like to be added to the monthly email newsletter list!
Please click below for the full newsletter:
For more information about CGI, see www.genomicinterpretation.org. CGI is offering several unique ELEVATEGENETICS programs that establish meaningful and actionable pathways to improve genetic/genomic testing, analysis and reporting. For payers, ELEVATEGENETICS metrics offer unique evaluations when selecting and contracting with laboratories. For laboratories, these programs offer a unique third-party review focusing on key aspects of the genetic/genomic testing process which can dramatically improve the accuracy of test findings. For providers and consumers, CGI offers a number of resources to better understand the complex landscape of precision medicine.
# # #
The Center for Genomic Interpretation – www.genomicinterpretation.org
The Center for Genomic Interpretation (CGI) is an independent 501(c)(3) nonprofit organization with the mission to save and improve lives through encouraging careful stewardship of clinical genetics, genomics and precision medicine. Too frequently the precision medicine goals of patients and their providers are unknowingly thwarted by inaccurate or ineffective genetic or genomic testing. We facilitate the realization of value from among the confusing scramble of the new precision medicine era. The CGI team consists of clinical genetics and genomics scientific leaders, healthcare policy veterans, experienced business professionals, and others dedicated to helping stakeholders achieve the vision and promise of precision medicine. CGI offers a range of programs and services targeted to all stakeholders including patients, providers, payers, pharmaceutical developers, policy makers and laboratories.
The post April 2022 – The Data Driven Point of View Newsletter. FDA Oversight Needed So Lab Tests Do More GOOD than HARM appeared first on Center for Genomic Interpretation.